奥锐特: 奥锐特药业股份有限公司关于以集中竞价交易方式回购公司股份的进展公告

Group 1 - The company announced a share repurchase plan with a total expected amount between 60 million and 120 million RMB [1][2] - The repurchase will be conducted through centralized bidding and is intended for the conversion of the company's convertible bonds [1][2] - As of May 31, 2025, the company has repurchased a total of 1.3609 million shares, representing 0.34% of the total share capital, with a total expenditure of approximately 27.09 million RMB [2] Group 2 - The repurchase price ranged from 18.83 RMB to 21.00 RMB per share [1][2] - The board of directors approved the repurchase plan with unanimous consent during the twelfth board meeting [1] - The repurchase period is set to last for up to 12 months following the board's approval [1]